As for production, research and development, Chongqing Pharmaceutical Group enjoys drug production and research and development enterprises like Kerui Pharm, Yaoyou Pharm, Peace Pharmacy, Chongqing Pharmaceutical Research Institute, etc.

The Group enjoys quality research and development team, including over 500 researchers, nearly a half of researchers have medium and senior technical title; dozens of experts appointed externally and has established long-term cooperation relationship with several domestic and foreign research institutes.

The Group possesses complete new drug research and development system for discipline, good scientific research facility, advanced testing and experimental apparatus, and sufficient industrial test equipment.

Diversified research and development project: including new product, API, chemical drug, traditional Chinese medicine, plant drug, biochemical drug, Chinese and western medicine preparation, etc.

Chongqing Pharmaceutical Group enjoys nearly one hundred years’ drug production history, a complete industrial chain from API to preparation, world first class preparation production equipment and complete production quality management system.

The Group has several preparation production lines meeting GMP specification and several API production workshop meeting GMP and cGMP standard.

The Group has over 800 drug approval numbers, nearly 700 types of products and nearly 200 products listed in “National Essential Medicine List”.

The Group possesses several national unique drug types: compound bear bile nasal spray, chdecalciferolchdes terol, cinnamon powder for reducing summer-heat effect, ceftazidime and tazobactam sodium for injection, vertigo-eliminating and syncope-stopping tablets, Guixiong pollen oral liquid, Cansuobaji oral liquid, etc. and other dominant varieties like lysimachia christinae hance, artemisinin, Longqing capsule, valpromide, etc.

Chongqing Pharmaceutical Group is the medical enterprise with the most types and most complete specifications of drugs in Western China, which operates over 70,000 medical products of various specifications, including prescription drug, over-the-counter drug, vaccine, anesthetic, Chinese herbal medicine, health care products, etc.

As per the market demand and development condition, the Group put forward “20 words development strategy”, i.e.: one map, two networks, three-level distribution, four business types and five supports.

The Group has over 800 drug approval numbers, nearly 700 types of products and nearly 200 products listed in “National Essential Medicine List”.

Take one map of Western China as the foothold, have a closer look at southwest and have a farther look at northwest; combine traditional sales network with emerging Internet; three-level distribution system covers provincial, surrounding and county-level distribution centers, town and village terminal as well as internal logistics from general warehouse of pharmacy to outpatient pharmacy and hospital pharmacy; mutually coordinate four business types: direct sale, distribution, retail sale, and terminal distribution; common supports of organizational structure, financing guarantee, information system, incentive mechanism and enterprise culture.

The Group has a modern medicine logistics center which is first class in China and leading in western China. The Group has established over 40 allocation and distribution centers with storage area of over 200,000 square meters.

The Group has a modern medicine logistics center which is first class in China and leading in western China. The Group has established over 40 allocation and distribution centers with storage area of over 200,000 square meters.

In addition to logistics nodes, the Group has established long-term cooperation with various professional shipping units like highway, railway, air, postal, etc. and realized drug distribution in southwest China even the whole country.